Good Morning! Hey, there! It's Chris from Elite Trade Club, here to give you this morning's premarket trading news. Today is Wednesday, November 1st. I hope you have a great day in the market. Now, let's get ready to trade! Markets ð U.S. indexes notched modest gains on Tuesday. The Dow added 0.3%, while the Nasdaq gained 0.4%, and the S&P 500 advanced 0.6%. The small-cap Russell 2K outperformed with a 0.9% gain. However, futures are reversing course in today's premarket. S&P 500 contracts are currently carrying a 0.4% loss. Sponsored [This Nanotech Could Potentially Disrupt a $3.7 Billion Market]( A little-known company is developing a new nanotechnology that instantly repels viruses, bacteria, and even the strongest superbugs. It's being described as 'the most innovative invention to have a positive impact on the future'. And you have a chance to get in on the company early - before it potentially starts down the path to commercialization. [Get a full report on this innovative tech here]( Premarket Highlights ð ð¤ Corporate Earnings Roundup Saddle up, partner! It's time to roundup this week's corporate earnings: Toyota Motor [TM]: Shares are racing up the charts, closing 4.7% higher in Tokyo. Why? A weak yen and North Americans and Japanese driving off in droves of hybrid vehicles. The U.S. receipts ain't too shabby either. Yum China [YUMC]: This one's about as flat as a day-old soda. U.S. shares took a dip in pre-market trading after they warned about waning consumer appetite. Their Hong Kong shares? Let's just say, not the best year. AMD [AMD]: What's the word? Uh, not good. Shares slipped by 2.6% in pre-market trading. Though sales for the next quarter look dicey, the company says their AI chip business is gathering steam.
On Deck ð¤ Keep an eye out for DuPont de Nemours [DD], Kraft Heinz [KHC], and CVS Health [CVS]. These big guns are set to disclose their earnings before the roosters even start crowing. What to Watch Today ð ADP Employment & Fed Decision
The latest ADP employment report drops today at 8:30 a.m. ET, and it will give investors a preview of what to expect from the upcoming October jobs report. Median forecasts estimate the economy added 130,000 jobs last month, which would mark a substantial increase from the prior month's 89,000 total. Another key point on investors minds' is interest rates. The Fed will announce its latest policy decision today at 2 p.m., followed by Chairmain Jerome Powell's press conference at 2:30. The market is expecting the Fed will hold rates steady, so we could see substantial volatility and declines if the central bank lifts rates unexpectedly. Major Earnings ð° CVS Health Corporation [CVS] ... AM
Humana [HUM] ... AM
Estee Lauder Companies [EL] ... AM
Apollo Global Management [APO] ... AM
Qualcomm Incorporated [QCOM] ... PM
Mondelez International [MDLZ] ... PM
Airbnb [ABNB] ... PM
McKesson Corporation [MCK] ... PM
PayPal Holdings [PYPL] ... PM
Aflac Incorporated [AFL] ... PM Economy ð - ADP employment [Oct] ... 8:15a
- Treasury quarterly refunding statement [Q4] ... 8:30a
- S&P U.S. manufacturing PMI [Oct] ... 9:45a
- Job openings [Sep] ... 10:00a
- ISM manufacturing [Oct] ... 10:00a
- Construction spending [Sep] ... 10:00a Running Hot ð¥ Gainers
- Kubient [KBNT] >> +24.0%
- GDEV [GDEV] >> +20.7%
- 60 Degrees Pharma [SXTP] >> +20.6% Decliners
- Altisource Asset Mgm.t [AAMC] >> (40.9%)
- WeWork [WE] >> (37.7%)
- Paycom Soft [PAYC] >> (37.5%) Caesars Entertainment [CZR] - Last Close: $39.89 Strong earnings are boosting shares of Caesars. The casino company reported stronger-than-expected Q3 results after Tuesday's closing bell, and it's running hot ahead of today's open. Caesars reported EPS of $0.34 against the consensus of $0.29. Revenues jumped 3.7% to $3 billion, also topping the Street's $2.93 billion estimate. The strong quarter is propelling CZR to the top of the charts this morning. It's this morning's top S&P 500 stock with a 5.0% gain. My Take: CZR is down roughly 33% over the past three months, but volume has spiked in recent days. A pivot higher could be unfolding here. Cellectis [CLLS] - Last Close: $0.97 Cellectis just announced a major deal. This morning, the biotech firm announced a new strategic collaboration agreement with Astra Zeneca [AZN] that has some notable perks for the company. The collaboration will leverage Cellectisâ gene editing and manufacturing capabilities to develop up to 10 novel cell & gene therapy candidate products. In exchange, Cellectis will receive a $25 million upfront payment, plus up to a $220 million equity investment, milestone payments, and tiered royalties on sales. CLLS is this morning's hottest stock with a 167.0% on active trading volume. My Take: This could be a game-changing deal for CLLS. Anytime Big Pharma wants to buy into a tiny company, it's usually a good sign. This could be the beginning of a new trend line for the stock. Monopar Therapeutics [MNPR] - Last Close: $0.43 Monopar Therapeutics is rallying on new clinical data. The tiny biopharma firm said an ongoing Phase 1b trial of camsirubicin showed the drug produced notable tumor reduction benefits. Monopar will present the complete data later today at the 2023 Connective Tissue Oncology Society's Annual Meeting. The company said patients achieved stable disease and experienced an roughly 20% tumor size reduction at last study scan. MNPR is up 30.8%, and trading volume is spiking in the premarket. My Take: MNPR's rally could be affected when the company releases the complete data later today. So far, it seems like the market is pretty bullish, but that could change quickly if the data doesn't live up to expectations. SatixFy Communications [SATX] - Last Close: $0.38 SatixFy Communications just closed on a lucrative deal. The tiny satellite company completed the sales of its digital payload division to MDA for a purchase price of $60 million. The deal also includes an additional $20 million in advanced payments under new commercial agreements between the companies. SatixFy said the sale also establishes its cooperation with MDA and is expected to bring its solutions to broader markets and new customers. The company will also retain its related ASIC intellectual property and new chips' development following the transaction. SATX is up 23.6% on news of the deal's closing. My Take: SATX has had a rough run lately, but space is a hot industry. If this stock can straighten up and fly right, it could garner more support from the market. That's it for today! Thanks for reading, and good luck out there! Best Regards, Chris D. -- Elite Trade Club P.S... Want alerts delivered straight to your cell every morning for free?* Text ELITE to 47121 to sign up now and get our watchlists sent directly to your phone! Or text CLOSE to 47121 to get on the mobile alert list for our Closing Bell Roundup report, featuring the day's top winners and losers. *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails.
[Bots click here]( 1969 S. ALAFAYA TRAIL
Orlando FL 32828
USA [Unsubscribe]( | [Change Subscriber Options](